Untreated follicular NHL
MabThera-based therapy is the standard of care in FL, and clinical studies demonstrate that it is now possible to change the natural history of the disease and achieve prolonged survival.1–7
References
1. Marcus R, Imrie K, Belch A, et al. Blood 2005;105:1417–1423.
2. Marcus R, Solal-Celigny P, Imrie K, et al. Blood 2006;108:146a (Abstract 481).
3. Buske C, Hoster E, Dreyling M, et al. Blood 2006;108:1504–1508.
4. Foussard C, Mounier N, Van Hoof A, et al. J Clin Oncol 2006;24(Suppl. 18 Pt I):424s (Abstract 7508).
5. Herold M, Haas A, Srock S,et al. Blood 2006;108:147a (Abstract 484).
6. Hiddemann W, Knebba M, Dreyling M, et al. Blood 2005;106:3725–3732.
7. Salles GA, Foussard C, Nicolas M, et al. Blood 2004;104:49a–50a (Abstract 160).
